Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanhong Zeng

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Stem Cell Reviews and Reports|December 22, 2019
Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical ApplicationFanhong Zeng, Yue Zhang, Xu Han, et al.
Molecular Therapy. Nucleic Acids|May 17, 2021
HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2021
CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
Frontiers in Genetics|February 12, 2021
Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic SteatohepatitisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
Stem Cell Research & Therapy|October 16, 2020
Lineage tracing: technology tool for exploring the development, regeneration, and disease of the digestive systemYue Zhang, Fanhong Zeng, Xu Han, et al.
Computational and Structural Biotechnology Journal|June 7, 2021
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinomaFanhong Zeng, Yue Zhang, Xu Han, et al.
Frontiers in Immunology|February 12, 2021
Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression PatternsFanhong Zeng, Yue Zhang, Xu Han, et al.
Cancers|May 13, 2026
STEA: Histologically Validated and Reference-Independent Major Cell-Type Annotation for Spatial Transcriptomics Reveals Relevant Cellular Organization and Architecture of Tumor MicroenvironmentQian Li, Qingyang Zhang, Fanhong Zeng, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2019
Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathwayZhi Zhang, Huiqing Wen, Jun Weng, et al.
International Journal of Biological Sciences|November 28, 2022
Erratum: Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: ErratumYue Zhang, Fanhong Zeng, Min Zeng, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Stem Cell Reviews and Reports|December 22, 2019
Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical ApplicationFanhong Zeng, Yue Zhang, Xu Han, et al.
Molecular Therapy. Nucleic Acids|May 17, 2021
HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2021
CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
Frontiers in Genetics|February 12, 2021
Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic SteatohepatitisZhi Zhang, Huiqing Wen, Bangjian Peng, et al.
Stem Cell Research & Therapy|October 16, 2020
Lineage tracing: technology tool for exploring the development, regeneration, and disease of the digestive systemYue Zhang, Fanhong Zeng, Xu Han, et al.
Computational and Structural Biotechnology Journal|June 7, 2021
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinomaFanhong Zeng, Yue Zhang, Xu Han, et al.
Frontiers in Immunology|February 12, 2021
Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression PatternsFanhong Zeng, Yue Zhang, Xu Han, et al.
Cancers|May 13, 2026
STEA: Histologically Validated and Reference-Independent Major Cell-Type Annotation for Spatial Transcriptomics Reveals Relevant Cellular Organization and Architecture of Tumor MicroenvironmentQian Li, Qingyang Zhang, Fanhong Zeng, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2019
Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathwayZhi Zhang, Huiqing Wen, Jun Weng, et al.
International Journal of Biological Sciences|November 28, 2022
Erratum: Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: ErratumYue Zhang, Fanhong Zeng, Min Zeng, et al.
Pageof 3